UFVLUUXGBXOCMA-UHFFFAOYSA-N
C29H27F2N7O3 — CID 155730077
Data last refreshed: (MolForge compound catalog, from PubChem)
About UFVLUUXGBXOCMA-UHFFFAOYSA-N
UFVLUUXGBXOCMA-UHFFFAOYSA-N (PubChem CID 155730077) has the molecular formula C29H27F2N7O3 and a molecular weight of 559.58 g/mol. Its IUPAC name is 1-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]-3-[1-(oxetan-3-yl)piperidin-4-yl]-5-pyridin-4-ylbenzimidazol-2-one.
Molecular Properties
| Compound Name | UFVLUUXGBXOCMA-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 155730077 |
| Molecular Formula | C29H27F2N7O3 |
| Molecular Weight | 559.58 g/mol |
| Exact Mass | 559.21 |
| IUPAC Name | 1-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]-3-[1-(oxetan-3-yl)piperidin-4-yl]-5-pyridin-4-ylbenzimidazol-2-one |
| SMILES | O=c1n(Cc2ccc(-c3nnc(C(F)F)o3)cn2)c2ccc(-c3ccncc3)cc2n1C1CCN(C2COC2)CC1 |
| InChI | InChI=1S/C29H27F2N7O3/c30-26(31)28-35-34-27(41-28)20-1-3-21(33-14-20)15-37-24-4-2-19(18-5-9-32-10-6-18)13-25(24)38(29(37)39)22-7-11-36(12-8-22)23-16-40-17-23/h1-6,9-10,13-14,22-23,26H,7-8,11-12,15-17H2 |
| InChIKey | UFVLUUXGBXOCMA-UHFFFAOYSA-N |
| XLogP | 4.33 |
| TPSA | 104.10 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 559.58 |
| LogP ≤ 5 | 4.33 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155730077 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.